These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10735605)

  • 1. Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development.
    Boberg KM; Schrumpf E; Bergquist A; Broomé U; Pares A; Remotti H; Schjölberg A; Spurkland A; Clausen OP
    J Hepatol; 2000 Mar; 32(3):374-80. PubMed ID: 10735605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer.
    Ahrendt SA; Rashid A; Chow JT; Eisenberger CF; Pitt HA; Sidransky D
    J Hepatobiliary Pancreat Surg; 2000; 7(4):426-31. PubMed ID: 11180865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis.
    Rizzi PM; Ryder SD; Portmann B; Ramage JK; Naoumov NV; Williams R
    Gut; 1996 Feb; 38(2):265-8. PubMed ID: 8801209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
    Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
    J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras mutations in the bile of patients with primary sclerosing cholangitis.
    Kubicka S; Kühnel F; Flemming P; Hain B; Kezmic N; Rudolph KL; Manns M; Meier PN
    Gut; 2001 Mar; 48(3):403-8. PubMed ID: 11171833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoplastic Transformation of the Peribiliary Stem Cell Niche in Cholangiocarcinoma Arisen in Primary Sclerosing Cholangitis.
    Carpino G; Cardinale V; Folseraas T; Overi D; Grzyb K; Costantini D; Berloco PB; Di Matteo S; Karlsen TH; Alvaro D; Gaudio E
    Hepatology; 2019 Feb; 69(2):622-638. PubMed ID: 30102768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
    Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
    Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
    Wang X; Zhang J; Chen J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity.
    Kamp EJCA; Peppelenbosch MP; Doukas M; Verheij J; Ponsioen CY; van Marion R; Bruno MJ; Groot Koerkamp B; Dinjens WNM; de Vries AC
    Clin Transl Gastroenterol; 2021 Oct; 12(10):e00410. PubMed ID: 34608877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis.
    Bergquist A; Broomé U
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Nabeshima T; Hamada S; Taguchi K; Tanaka Y; Matsumoto R; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G419-G427. PubMed ID: 31961719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of brush cytology for dominant strictures in primary sclerosing cholangitis.
    Ponsioen CY; Vrouenraets SM; van Milligen de Wit AW; Sturm P; Tascilar M; Offerhaus GJ; Prins M; Huibregtse K; Tytgat GN
    Endoscopy; 1999 May; 31(4):305-9. PubMed ID: 10376457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma.
    Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D
    J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic Characterization of Cholangiocarcinoma in Primary Sclerosing Cholangitis Reveals Therapeutic Opportunities.
    Goeppert B; Folseraas T; Roessler S; Kloor M; Volckmar AL; Endris V; Buchhalter I; Stenzinger A; Grzyb K; Grimsrud MM; Gornicka B; von Seth E; Reynolds GM; Franke A; Gotthardt DN; Mehrabi A; Cheung A; Verheij J; Arola J; Mäkisalo H; Eide TJ; Weidemann S; Cheville JC; Mazza G; Hirschfield GM; Ponsioen CY; Bergquist A; Milkiewicz P; Lazaridis KN; Schramm C; Manns MP; Färkkilä M; Vogel A; ; Boberg KM; Schirmacher P; Karlsen TH
    Hepatology; 2020 Oct; 72(4):1253-1266. PubMed ID: 31925805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency of p53 and ras mutations in bile of patients with hepato-biliary disease: a prospective study in more than 100 patients.
    Müller P; Ostwald C; Püschel K; Brinkmann B; Plath F; Kröger J; Barten M; Nizze H; Schareck WD; Hauenstein K; Liebe S; Löhr JM
    Eur J Clin Invest; 2001 Mar; 31(3):240-7. PubMed ID: 11264652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
    Margalit M; Elinav H; Goldin E; Ilan Y
    Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients.
    Petmitr S; Pinlaor S; Thousungnoen A; Karalak A; Migasena P
    Southeast Asian J Trop Med Public Health; 1998 Mar; 29(1):71-5. PubMed ID: 9740272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial thrombophlebitis, dysplasia, and cholangiocarcinoma in primary sclerosing cholangitis.
    Martins EB; Fleming KA; Garrido MC; Hine KR; Chapman RW
    Gastroenterology; 1994 Aug; 107(2):537-42. PubMed ID: 8039630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.